These include the RyR2 (ryanodine receptor) and CASQ2 (calsequestrin) mutations.1 CPVT often presents during childhood and the adolescent years, with the main clinical manifestation of sudden syncope during exercise or episodes of emotional distress. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.